Condition

Circulating Tumor Cells.Breast

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting0

Common interventions1

Lead sponsors shown2

Clinical trials

2 shown

Does Anesthesia Technique Impact on the Long-term Outcome 5 and 10 Years After the First Intervention in Primary Breast Cancer Surgery? A Follow-up Analysis.NCT07689253 · 2025-09-01

COMPLETED

The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo DeviceNCT03006055 · 2016-04-01

UNKNOWN

Common interventions

Circulating tumor cellsDEVICE1

Leading sponsors

Beijing Viroad Biotechnology Co., Ltd. 1 University of Zurich 1

Trial status mix

COMPLETED1

UNKNOWN1

Phase mix

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.